| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1179/016164107X181815 |
| P698 | PubMed publication ID | 17439702 |
| P2093 | author name string | Aneesh B Singhal | |
| P2860 | cites work | Hyperbaric oxygen reduces neuronal death and improves neurological outcome after canine cardiac arrest | Q48344146 |
| Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome | Q48409936 | ||
| Videodensitometric estimation of the protective effect of hyperbaric oxygen in the ischemic gerbil brain | Q48465418 | ||
| Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model | Q48486480 | ||
| Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion | Q48531932 | ||
| Effects of hyperbaric oxygen on neurologic outcome for cerebral ischemia in rats | Q48555002 | ||
| Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model | Q48769278 | ||
| Evaluation of the apoptosis-related proteins of the BCL-2 family in the traumatic penumbra area of the rat model of cerebral contusion, treated by hyperbaric oxygen therapy: a quantitative immunohistochemical study | Q48821455 | ||
| Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats | Q48922395 | ||
| Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia | Q48957261 | ||
| Hyperbaric oxygen induces rapid protection against focal cerebral ischemia | Q48960973 | ||
| A pilot study of normobaric oxygen therapy in acute ischemic stroke | Q48972485 | ||
| Hyperbaric oxygen reduces cerebral blood flow by inactivating nitric oxide | Q49115245 | ||
| The Protective Effect of Hyperbaric Oxygenation in Experimental Cerebral Edema | Q49151871 | ||
| Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. | Q49157416 | ||
| Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia | Q49162220 | ||
| TREATMENT OF FOCAL CEREBRAL ISCHEMIA WITH HYPERBARIC OXYGEN. REPORT OF 4 CASES | Q51259821 | ||
| The effect of hyperbaric oxygen on the mental and verbal ability of stroke patients. | Q52121336 | ||
| THE EFFECT OF HYPERBARIC OXYGEN ON EXPERIMENTAL CEREBRAL INFARCTION IN THE DOG. WITH PRELIMINARY CORRELATIONS OF CEREBRAL BLOOD FLOW AT 2 ATMOSPHERES OF OXYGEN. | Q52765133 | ||
| Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. | Q52971113 | ||
| Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. | Q53852264 | ||
| HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia | Q28204574 | ||
| Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia | Q29615548 | ||
| Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest | Q29615549 | ||
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery | Q30913732 | ||
| Effect of hyperbaric oxygen therapy on survival after global cerebral ischemia in rats | Q32068876 | ||
| Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients | Q32113005 | ||
| Hyperbaric oxygen therapy for treatment of postischemic stroke in adult rats. | Q33422537 | ||
| Hyperbaric oxygen and neutrophil accumulation/tissue damage during permanent focal cerebral ischaemia in rats | Q33424926 | ||
| Eubaric hyperoxemia and experimental cerebral infarction | Q33425975 | ||
| Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study | Q33426461 | ||
| Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity | Q33431986 | ||
| Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats | Q33472241 | ||
| Mechanisms, challenges and opportunities in stroke | Q35120144 | ||
| Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. | Q35128814 | ||
| Mechanisms of hyperbaric oxygen and neuroprotection in stroke. | Q36115709 | ||
| Hyperbaric oxygen therapy of cerebral ischemia | Q36288828 | ||
| Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death | Q36944465 | ||
| Neurological improvement in chronic ischemic stroke following surgical brain revascularization | Q39690549 | ||
| Hyperbaric oxygenation as an adjunct therapy in strokes due to thrombosis. A review of 122 patients | Q40362381 | ||
| Hyperbaric oxygen in the treatment of acute ischemic stroke: an unsettled issue | Q40883444 | ||
| Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. | Q42171702 | ||
| Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion | Q43764317 | ||
| Free radical production and ischemic brain damage: influence of postischemic oxygen tension | Q43768495 | ||
| Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion | Q44032176 | ||
| A pilot study of hyperbaric oxygen in the treatment of human stroke. | Q44615847 | ||
| Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. | Q44827191 | ||
| Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial | Q44832888 | ||
| Normobaric hyperoxia--induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study | Q44904757 | ||
| Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats | Q44904760 | ||
| Trends in acute ischemic stroke trials through the 20th century | Q46087072 | ||
| Correlation between hyperbaric oxygen exposure pressures and oxidative parameters in rat lung, brain, and erythrocytes | Q46499183 | ||
| Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage | Q46509145 | ||
| Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia | Q46601724 | ||
| Hyperbaric oxygen increases survival following carotid ligation in gerbils | Q46697528 | ||
| Electron paramagnetic resonance-guided normobaric hyperoxia treatment protects the brain by maintaining penumbral oxygenation in a rat model of transient focal cerebral ischemia | Q46900349 | ||
| Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke | Q47189889 | ||
| Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats | Q47249636 | ||
| Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity | Q47978281 | ||
| Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats | Q48096756 | ||
| Hyperbaric oxygen and cerebral infarction in the gerbil | Q48199236 | ||
| Hyperbaric oxygen in acute ischemic stroke | Q48219672 | ||
| P433 | issue | 2 | |
| P921 | main subject | oxygen therapy | Q1988216 |
| P304 | page(s) | 173-183 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Neurological Research | Q15765622 |
| P1476 | title | A review of oxygen therapy in ischemic stroke | |
| P478 | volume | 29 |
| Q47906782 | Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment |
| Q33569474 | An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome |
| Q47123735 | Bimetallic lanthanide complexes that display a ratiometric response to oxygen concentrations |
| Q33594546 | Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: a continued promise for neuroprotection |
| Q59137588 | Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator |
| Q50302749 | Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders |
| Q35990395 | Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. |
| Q36211369 | Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke. |
| Q37409110 | Early changes in physiological variables after stroke. |
| Q41879966 | Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental stroke |
| Q33789577 | Early oxygen therapy does not protect the brain from vasogenic edema following acute ischemic stroke in adult male rats |
| Q46315900 | Effect of long-term normobaric hyperoxia on oxidative stress in mitochondria of the guinea pig brain |
| Q26772288 | Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity |
| Q43976540 | Effects of hyperoxia on 18F-fluoro-misonidazole brain uptake and tissue oxygen tension following middle cerebral artery occlusion in rodents: Pilot studies |
| Q34956731 | Effects of normobaric oxygen on the progression of focal cerebral ischemia in rats |
| Q36072522 | Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models |
| Q42851048 | Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats |
| Q33419743 | Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms |
| Q28067839 | Hyperbaric oxygen therapy in experimental and clinical stroke |
| Q35595585 | Hyperbaric oxygen therapy promotes neurogenesis: where do we stand? |
| Q47630318 | Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats |
| Q39319634 | Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide. |
| Q40204462 | Implementation of a titrated oxygen protocol in the out-of-hospital setting |
| Q33594541 | In vivo electron paramagnetic resonance oximetry and applications in the brain |
| Q34778251 | Inhibition of gp91(phox) contributes towards normobaric hyperoxia afforded neuroprotection in focal cerebral ischemia |
| Q42124550 | Interrelations between blood-brain barrier permeability and matrix metalloproteinases are differently affected by tissue plasminogen activator and hyperoxia in a rat model of embolic stroke |
| Q38998698 | NADPH oxidase 2 does not contribute to early reperfusion-associated reactive oxygen species generation following transient focal cerebral ischemia. |
| Q45754622 | NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia-reperfusion damage |
| Q33902181 | Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy |
| Q81920376 | Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model |
| Q36972068 | Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke |
| Q35554378 | Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia |
| Q36555842 | Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke |
| Q28070403 | Normobaric oxygen treatment in acute ischemic stroke: a clinical perspective |
| Q34171344 | Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia |
| Q33530454 | Oxygen-sensitive outcomes and gene expression in acute ischemic stroke |
| Q36496980 | Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. |
| Q42766402 | Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra |
| Q52576389 | Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke. |
| Q24600568 | Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation |
| Q33765349 | RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION). |
| Q42262869 | Spatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation |
| Q37701718 | The Continued Promise of Neuroprotection for Acute Stroke Treatment |
| Q58578972 | The Effect of Hyperbaric Oxygen Therapy on Functional Impairments Caused by Ischemic Stroke |
| Q38160922 | The medical use of oxygen: a time for critical reappraisal |
| Q37409006 | Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 1: Theoretic basis |
| Q48597343 | Time course of neuroprotection induced by normobaric hyperoxia in focal cerebral ischemia |
| Q30370528 | Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke. |
Search more.